Based on the positive Phase 1 results and approval from Canadian regulatory authorities, Medicago has decided to commence the Phase 2/3 clinical trial with ... Nov 13
... Nov 12
PMIBV and MTPC will contribute additional funding to support Medicago’s efforts to develop a COVID-19 vaccine candidate.... Oct 24
After Canada, Switzerland signs vaccine deal with Moderna... Aug 08
Canada has signed separate deals with Pfizer Inc and Moderna Inc to supply millions of doses of their experimental coronavirus vaccines... Aug 06
Plant based formulations with adjuvants from Medicago enters trial... Jul 18
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine ... Jul 09
-Advertisements-